Mastering the New Era of VM-22: From Regulatory Burden to Strategic Advantage
Authored by James Beck, Senior Strategy Advisor, US, RNA Analytics
The shift to VM-22 represents the most significant change to U.S. annuity reserving in decades. By moving away from the prescriptive, formulaic CARVM approach, the new Principle-Based Reserving (PBR) framework requires insurers to model complex, stochastic future states.
We recognize that VM-22 is not merely a calculation change, but a full operational overhaul. Our R3S Software Suite is purpose-built to navigate this new landscape, ensuring your firm stays compliant, capitalized, and competitive in an increasingly sophisticated market.
Overcoming the Technical Hurdles of PBR
Transitioning to PBR introduces technical hurdles that legacy systems simply weren’t built to clear. Insurers must now calculate Stochastic Reserves (SR) at a CTE 70 level, a task requiring thousands of scenarios that can paralyze underpowered modeling environments.
Furthermore, VM-22 demands a holistic view of asset-liability integration, reflecting realistic reinvestment and dynamic hedging strategies. Compounding this complexity is the "double-run" burden of the Additional Standard Projection Amount (ASPA), which essentially doubles the computational workload for every reporting cycle.
The RNA Edge: High-Performance Governance
RNA Analytics provides the high-performance engine and governance framework required to thrive under these mandates.
Audit-Ready Transparency: Our "Glass Box" philosophy ensures audit-ready transparency with full drill-down capabilities, allowing teams to isolate the drivers of reserve volatility and meet rigorous VM-31 disclosure standards with total confidence.
Seamless GOES Integration: Beyond simple compliance, R3S allows you to transform VM-22 from a cost center into a strategic asset. By aligning reserves more closely with economic reality, firms can potentially free up trapped capital and use high-resolution stochastic data to refine product pricing against tail risks.
Expertise You Can Trust To ensure a smooth transition, RNA Analytics has established partnerships with trusted US-based consulting firms such as Oliver Wyman and others. Their deep expertise in US regulations can be provided as part of our offering, giving you a comprehensive solution that pairs world-class modeling software with localized regulatory insight.
While the mandatory deadline is January 1, 2029, the complexity of GOES integration and model validation necessitates an immediate start.